Strategic Investment Advisors Merck & Co., Inc. Transaction History

Strategic Investment Advisors

$909 Million
Q3 2024

A detailed history of Strategic Investment Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Strategic Investment Advisors holds 10,065 shares of MRK stock, worth $989,993. This represents 0.13% of its overall portfolio holdings.

Number of Shares

10,065

Previous 10,412 3.33%

Holding current value

$989,993

Previous $1.29 Million 11.4%

% of portfolio

0.13%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$111.15 - $128.97 $38,569 - $44,752	-347 Reduced 3.33%	10,065 $1.14 Million
Q2 2024 Jul 22, 2024	SELL	$123.8 - $132.96 $3,837 - $4,121	-31 Reduced 0.3%	10,412 $1.29 Million
Q1 2024 Apr 22, 2024	BUY	$113.24 - $131.95 $12,343 - $14,382	109 Added 1.05%	10,443 $1.38 Million
Q4 2023 Jan 10, 2024	SELL	$100.18 - $109.02 $153,175 - $166,691	-1,529 Reduced 12.89%	10,334 $1.13 Million
Q3 2023 Oct 24, 2023	BUY	$102.95 - $114.33 $21,516 - $23,894	209 Added 1.79%	11,863 $1.22 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $270,656 - $295,002	2,492 Added 27.2%	11,654 $1.34 Million
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $307,275 - $342,857	-2,985 Reduced 24.57%	9,162 $974,000
Q4 2022 Jan 19, 2023	BUY	$87.44 - $112.11 $262 - $336	3 Added 0.02%	12,147 $0
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $33,727 - $37,889	399 Added 3.4%	12,144 $1.05 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $131,162 - $148,679	-1,571 Reduced 11.8%	11,745 $1.07 Million
Q1 2022 Apr 28, 2022	BUY	$73.51 - $82.4 $244,053 - $273,568	3,320 Added 33.21%	13,316 $1.09 Million
Q4 2021 Jan 26, 2022	BUY	$72.28 - $90.54 $130,537 - $163,515	1,806 Added 22.05%	9,996 $766,000
Q3 2021 Oct 19, 2021	BUY	$71.68 - $78.83 $46,807 - $51,475	653 Added 8.66%	8,190 $615,000
Q2 2021 Jul 22, 2021	SELL	$70.31 - $77.77 $283,068 - $313,102	-4,026 Reduced 34.82%	7,537 $586,000
Q1 2021 Apr 14, 2021	SELL	$68.86 - $81.11 $848,561 - $999,518	-12,323 Reduced 51.59%	11,563 $891,000
Q4 2020 Jan 13, 2021	BUY	$71.77 - $79.65 $933,153 - $1.04 Million	13,002 Added 119.46%	23,886 $1.95 Million
Q3 2020 Oct 14, 2020	BUY	$73.18 - $82.95 $248,958 - $282,195	3,402 Added 45.47%	10,884 $903,000
Q2 2020 Aug 04, 2020	BUY	$70.42 - $80.13 $29,365 - $33,414	417 Added 5.9%	7,482 $579,000
Q1 2020 Apr 13, 2020	BUY	$63.36 - $87.82 $196,479 - $272,329	3,101 Added 78.23%	7,065 $544,000
Q4 2019 Jan 23, 2020	BUY	$77.58 - $87.54 $26,842 - $30,288	346 Added 9.56%	3,964 $360,000
Q3 2019 Oct 25, 2019	BUY	$76.08 - $82.93 $32,942 - $35,908	433 Added 13.59%	3,618 $305,000
Q2 2019 Jul 23, 2019	BUY	$69.84 - $81.59 $31,428 - $36,715	450 Added 16.45%	3,185 $266,000
Q1 2019 Apr 30, 2019	BUY	$69.58 - $79.36 $190,301 - $217,049	2,735 New	2,735 $227,000

Others Institutions Holding MRK

# of Institutions

3,814

Shares Held

1.88B

Call Options Held

14.6M

Put Options Held

13.2M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.

Account

Strategic Investment Advisors Merck & Co., Inc. Transaction History